Search filters

Molecular responses at 3 and 6 months after switching to a second-generation tyrosine kinase inhibitor are complementary and predictive of long-term outcomes in patients with chronic myeloid leukemia who fail imatinib.

Image Image of a generic work. The text above it indicates that there is no free image of the work available, and that if you own one, you can click on the placeholder link to upload it.
Description scientific article published on 20 November 2014
Author/s

author: Israel Bendit 

Publication date November 20, 2014
Language
Country of origin
Wikipedia link
Copyright status
Missing/wrong data? Edit Wikidata item